By Tina Bellon
On Thursday, another South Carolina jury did not have a solution to a review of the case, which a woman said to her family's long-term use of Johnson & Johnson baby powder for the death of asbestos-based cancer.
The case of Bertila Boyd-Bostic, who died of rare cancer in 2017 at the age of 30, is the most recent experiment in the United States that focuses on allegations that the company's talcum powder contains cancerous diseases, causing asbestos.
In May of Charleston, Darlington County Court of Common Pleas, a deadlock jury did not reach the first trial.
J & J, who denies the allegations, has so far lost two trials and won three trials as to whether Johnson's Baby powder mesothelioma is closely linked to asbestos exposure. Jury studies in four cases of mesothelioma have led to mulches because the jurors could not reach a consensus or because the applicant died.
J & J faced about 11,700 American debates in Thursday's statement that it believed that the upheavals and disclaimers reflected the diligent scrutiny of "lawyers" in the cases.
"We are looking forward to a new research that sets out our defense, based on decades of independent, non-trial scientific assessments that have not been found that Johnson's Baby Powder contains asbestos," the company said.
Boyd-Bostic's family lawyer Christopher Swett said in a statement that the applicants were disappointed with Thursday's result. Swett said the trial judge had urged the parties to consider the solution, but J & J "refuses to be fair and take responsibility."
In New Jersey, New Jersey, New Jersey, that it has not considered the settlement of talc cases and is currently appealing against all jury members.
Over 11,700 talc litigation involving more than 9,700 are related to claims over ovarian cancer, recent records of federal court in New Jersey, where most of the cases have been consolidated, showed.
The rest of the applicants claim that asbestos J & J talc has caused them to develop mesothelioma.
J & J has been fighting for tonsil cancer legislation for several years, but litigation has been moving over the last few months to include allegations of asbestosis.
In July, the Missouri Jury hit J & J with a massive $ 4.69 billion judgment in the first trial involving asbestos contamination, causing ovarian cancer to 22 women. This decision is the subject of a complaint. (Reporting by Tina Bellon Editing by Leslie Adler)
Our Standards: Thomson Reuters Trust Principles.